Based on the HIV Phase 3 trial approval, I wonder if it is possible or would make sense to fix the BLA application and refile in order to have the biologics license ready to go--even if we don't use it for the HIV antiviral therapy. At least then it would be ready to go for manufacturing for the next indication.
Or would they simple start a new application? If that's the case why not do it now since we have an HIV approval (even if we don't use the approval of the HIV antiviral indication). That way we would be ready to go when the next indication is approved.